A Prognostic Signature Based on Immunogenomic Profiling Offers Guidance for Esophageal Squamous Cell Cancer Treatment

Our study aimed to develop an immune prognostic signature that could provide accurate guidance for the treatment of esophageal squamous cell cancer (ESCC). By implementing Single-Sample Gene Set Enrichment Analysis (ssGSEA), we established two ESCC subtypes (Immunity High and Immunity Low) in GSE536...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jianyao, Tang, Ting, Zhang, Baohui, Li, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943886/
https://www.ncbi.nlm.nih.gov/pubmed/33718151
http://dx.doi.org/10.3389/fonc.2021.603634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943886/
https://www.ncbi.nlm.nih.gov/pubmed/33718151
http://dx.doi.org/10.3389/fonc.2021.603634

Ejemplares similares